Research has documented the drastic reduction of unintentional poisonings of children since the introduction of child resistant (CR) packaging. However, studies also indicate that consumers report difficulty using CR packages, in part because tests which determine the 'senior friendliness' of CR designs that are used throughout the world disallow people with 'overt or obvious' disabilities from being test subjects. Our review of drug package usability suggests that the current tests of CR packaging can and should be revised to correct this problem. We use US legislation, regulation and data to exemplify these points, but the conclusions are applicable to all protocols that include the exclusionary provision.
Introduction
The testing protocols for senior friendly ⁄ child resistant (CR) packaging frequently exclude people with 'overt or obvious disabilities' and those who are unable to follow written direc tions (people with visual impairments and illit erate subjects) as eligible test subjects. These exclusionary practices do not adequately honour the ethical principle of justice.
A review of the evolution of protocol testing for senior friendly ⁄ CR packaging is presented. This is followed by a discussion of ethical prin ciples that should undergird research involving human subjects and problems the exclusionary practice presents, when viewed through this standard. Finally, we recommend changes to the protocol that would make it more objective and more inclusive. Although US documents are used to exemplify the ideas proposed, the implication exists wherever the exclusionary clause is present.
History
The unintentional poisoning of children as a result of the ingestion of household products became a noted problem shortly after the introduction of flavoured aspirin in 1943. By 1953, the first US Poison Control Center had been established to serve as a central source of information and treatment. This was followed by the establishment of a US Clearinghouse for Poison Control Centers in 1957. The Clearing house was started to coordinate the efforts of local centers, gather statistical data on poison ings, and provide diagnostic and therapeutic information.
During 4 (see Table 1 ). The CPSC remains responsible for the regulation of the CR packag ing of drugs and household chemicals. Addi tionally, in the years since the creation of CR packaging, the PPPA, and its underlying regula tions (16 CFR 1700-1750), have served as a model for many of the other laws, regulations and standards employed throughout the world 1 (See Table 1 for significant historical events associated with CR packaging and Table S1 for a summary of current CR protocols from around the world). During the first 25 years of US regulation , package designers were so focused on protecting children from poisoning that they frequently forgot to account for the convenience of the person needing the medication. The effect was the exclusion of many seniors and people with disabilities. This was largely because of the fact that the CPSC protocol for testing CR packages for 'senior friendliness' specified that adults aged 18-45 served as subjects for the adult portion of the test.
In actual usage situations, consumers older than 45 had difficulties with CR packages, and frequently circumvented child-resistant features. Many publications from this era, document the difficulties of consumers. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] By the early 1990s, the CPSC recognized the need to design a new test protocol in order to facilitate CR package designs that could be used more effectively by consumers. As a result, on July 21, 1995 the CPSC published a final rule that revised the senior-friendly portion of the test entitled, 'Requirements for the Special Packaging of Household Substances; Final Rule.' 18 Products packaged on or after July 21, 1998 had to comply with the new adult testing requirements (see Fig. 1 ). Because the US protocol was the first of its kind, it has served as the basis for numerous other protocols (see Table S1 ). This fact is referenced in the commonly adopted global standard, The current test protocol for ensuring senior friendly ⁄ child resistant packaging As a result of the 1995 revision, the current protocol employs 100 adults between the ages of 50 and 70 who do not have 'obvious or overt physical or mental disabilities.' 18 Figure 1 If, in the 5-min period, the person is not able to open or close the package, she ⁄ he is given a 2 min screening test (1 min for each screening package). This screening determines whether or not the participant is able to open packages that do NOT have CR features. The screening packages are: a plastic snap closure (see Fig. 2a ) and continuous thread (CT-see Fig. 2b ) plastic closure that have specific dimensions and requirements for preparation. If the person successfully opens and closes both screening packages, the participant continues with the The current test protocol for ensuring senior friendly/child resistant packaging 1-min-period testing the original CR package, otherwise the person is eliminated from testing and replaced with another participant. See Fig. 1 for a schematic of the current adult test, as dictated by the protocol.
A package passes the senior adult test if the senior adult use effectiveness (SAUE) is at least 90%. The SAUE is the percentage of adults who both opened the package in the first 5-min test period and opened and properly closed the package in the 1-min test period.
Despite the fact that the protocol was changed to test older adults (aged 50-70 as compared with 18-45), studies that have been done since the 1995 revision indicate that seniors continue to have difficulty with CR packages. [19] [20] [21] [22] [23] [24] This problem will continue, and likely grow, as the population ages, 25, 26 lives with increasing levels of chronic conditions (see Fig. 3 ) and engages in polypharmacy.
Ethical considerations with regard to the current protocol
An ethical analysis of the current protocol is grounded in four broadly accepted fundamental principles of biomedical ethics: 27 1. respect for persons, 2. beneficence, 3. non-maleficence, and 4. justice.
Respect for persons requires that the auton omy of individuals be honoured when decisions are made and actions are taken that affect the course of their lives; it also restricts us from forcing our will and values on others. Benefi cence enjoins us to do good, while non-malefi cence requires the avoidance of harm. Justice requires us to impartially consider the effects of our actions on all persons who will be influenced by them.
The entire process of regulating CR packaging has been driven, in large part, by the ethical principles of beneficence and non-maleficence.
• The inadvertent poisoning of children through toxic doses of medicine is clearly maleficent, and demanded corrective action in the middle of the 20th century.
• Protecting the vulnerable, a population including both children and the ill, is benefi cent; children are protected through the use of CR packaging, and the general population of ill persons is protected from undue difficulty in gaining access to medication through the testing process.
• Some of the restrictions on the testing process protect industry from undue burdens (benefi cence and non-maleficence) that might result from too-stringent requirements in the regu lations. For example, the clause in the PPPA that CR 'does not mean packaging which all such children cannot open or obtain a toxic or harmful amount within a reasonable time' makes it clear that packaging does not need be absolutely impervious to children to pass the protocol.
• Likewise, the stipulation that test subjects must be 'normal adults' is also intended to protect industry from an undue burden in designing and manufacturing packaging.
The obvious success 28, 29 of the legislated and regulated design and use of CR packaging is to be celebrated. However, we argue that the ethical principle of justice is inadequately honoured in the current legislation and regu lations because the needs of vulnerable popu lations, people with disabilities and consumers who experience difficulties opening CR pack ages, are not being met. We acknowledge that a major step toward serving vulnerable populations was taken with the 1995 revision. Additionally, the law's allowance for the use of non-CR prescription packages upon request for prescription drugs or in a single size for OTCs, aids accessibility. But does the current protocol for evaluating ease of use go far enough? Research continues to indicate difficulties associated with the use of CR packaging, [19] [20] [21] [22] [23] [24] [30] [31] [32] [33] [34] and consumers who are forced to choose non-CR systems are not afforded the CR protections that they provide. It appears to us that the regulations continue to be hampered by the regulatory interpretation of the 'normal adults' clause in the legislation. The vagueness of this stipulation and its neces sarily subjective interpretation by test adminis trators has unintentionally contributed to the continuing difficulties reported by many seniors in opening drug packages.
Proposal
The visual screening for overt or obvious dis abilities should be removed from the protocol on several grounds. This change can be made at the regulatory level by defining 'normal adult' (the language in the legislation) as an individual who can pass the objective screening test. Such an interpretation is within the spirit of the law because the legis lation clearly concerns the ability to open medical packages and the objective screening test guarantees that only adults with that ability serve a test subjects.
Conclusion
Although children, 'normal' adults, industry, and society as a whole have benefited from the implementation of this law, a large and growing vulnerable population of seniors and people with disabilities, in particular those who share living space with children, are disserved by the status quo. US Census 2000 enumerated, for the first time, the number of grandparents that were co-residents with grandchildren under the age of 18. The Census statistics indicated that 5.8 mil lion households (or 3.6% of those reporting) reported this living arrangement; 35 of these, 2.4 million indicated themselves to be 'caregiv ers' for their grandchild. Undoubtedly, even more grandparents are the benefactors of visits from children. For all of these households, the use of non-CR packaging has the potential to put children at risk. Through this article, we hope to begin a movement to change the test protocols throughout the world, to better serve aging populations, people with disabilities, and the children in their lives.
